Jazz Pharmaceuticals
JAZZ
100,93 €
Share price
-0.66%
Change (1 day)
-1.75%
Change (1 year)
Categories
Jazz Pharmaceuticals (JAZZ) - Cash on Hand
Cash on Hand as of March 2025 : €2.22 Billion
According to Jazz Pharmaceuticals's latest financial reports the company has €2.22 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Jazz Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | €2.87 B | 95.5% |
| 2023-12-31 | €1.47 B | 79.03% |
| 2022-12-31 | €0.82 B | 57.35% |
| 2021-12-31 | €0.52 B | -69.88% |
| 2020-12-31 | €1.73 B | 80.3% |
| 2019-12-31 | €0.96 B | 33.42% |
| 2018-12-31 | €0.72 B | 43.9% |
| 2017-12-31 | €0.50 B | 23.7% |
| 2016-12-31 | €0.40 B | -55.22% |
| 2015-12-31 | €0.90 B | 60.79% |
| 2014-12-31 | €0.56 B | 22.03% |
| 2013-12-31 | €0.46 B | 57.46% |
| 2012-12-31 | €0.29 B | 140.75% |
| 2011-12-31 | €0.12 B | 261.04% |
| 2010-12-31 | €33.67 M | 209.39% |
| 2009-12-31 | €10.88 M | -41.26% |
| 2008-12-31 | €18.53 M | -73.72% |
| 2007-12-31 | €70.5 M | 17.84% |
| 2006-12-31 | €59.83 M | 243.83% |
| 2005-12-31 | €17.4 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Endo International
ENDPQ | €0.67 B | -69.75% | 🇮🇪 Ireland |
 AmerisourceBergen
ABC | €1.20 B | -45.98% | 🇺🇸 USA |
 Novartis NVS | €6.22 B | 179.79% | 🇨🇭 Switzerland |
 Teva Pharmaceutical Industries TEVA | €1.46 B | -34.02% | 🇮🇱 Israel |